Safety of recombinant zoster vaccine: a retrospective study of 622 rheumatology patients.

Tiphaine LenfantYuxuan JinElizabeth KirchnerRula A Hajj-AliLeonard H CalabreseCassandra Calabrese

Published in: Rheumatology (Oxford, England) (2021)

RZV administration in patients with IMIDs was generally well-tolerated, though mild flares were not uncommon in the first 12 weeks after vaccination. These data may provide useful information for patient education when considering RZV administration.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
healthcare
prognostic factors
peritoneal dialysis
electronic health record
systemic lupus erythematosus
patient reported outcomes
rheumatoid arthritis
deep learning
data analysis
gestational age